4JP4 | pdb_00004jp4

Mmp13 in complex with a reverse hydroxamate Zn-binder


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.43 Å
  • R-Value Free: 
    0.175 (Depositor), 0.193 (DCC) 
  • R-Value Work: 
    0.151 (Depositor) 
  • R-Value Observed: 
    0.152 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4JP4

Ligand Structure Quality Assessment 


This is version 1.1 of the entry. See complete history

Literature

Hydantoin based inhibitors of MMP13--discovery of AZD6605.

De Savi, C.Waterson, D.Pape, A.Lamont, S.Hadley, E.Mills, M.Page, K.M.Bowyer, J.Maciewicz, R.A.

(2013) Bioorg Med Chem Lett 23: 4705-4712

  • DOI: https://doi.org/10.1016/j.bmcl.2013.05.089
  • Primary Citation Related Structures: 
    4JP4, 4JPA

  • PubMed Abstract: 

    Piperidine ether and aryl piperazine hydantoins are reported as potent inhibitors of MMP13. A medicinal chemistry campaign focused on replacing the reverse hydroxamate zinc binding group associated with historical inhibitors with a hydantoin zinc binding group then optimising MMP13 potency, solubility and DMPK properties whilst maintaining good selectivity over MMP14. A number of high quality candidates were progressed and following rat and dog safety evaluation, AZD6605 (3m) was identified as a candidate drug.


  • Organizational Affiliation
    • Oncology Innovative Medicines, AstraZeneca R&D Boston, 35 Gatehouse Drive, Waltham, MA 02451, USA. chris.desavi2@astrazeneca.com

Macromolecule Content 

  • Total Structure Weight: 40.53 kDa 
  • Atom Count: 3,234 
  • Modeled Residue Count: 331 
  • Deposited Residue Count: 346 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
Collagenase 3
A, B
173Homo sapiensMutation(s): 0 
Gene Names: MMP13
EC: 3.4.24
UniProt & NIH Common Fund Data Resources
Find proteins for P45452 (Homo sapiens)
Explore P45452 
Go to UniProtKB:  P45452
PHAROS:  P45452
GTEx:  ENSG00000137745 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP45452
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 4 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
AZ4

Query on AZ4



Download:Ideal Coordinates CCD File
H [auth A],
N [auth B]
N-[(2S)-4-(5-fluoropyrimidin-2-yl)-1-({4-[5-(2,2,2-trifluoroethoxy)pyrimidin-2-yl]piperazin-1-yl}sulfonyl)butan-2-yl]-N-hydroxyformamide
C19 H23 F4 N7 O5 S
BEMGDWJRAZUSRP-HNNXBMFYSA-N
ZN

Query on ZN



Download:Ideal Coordinates CCD File
C [auth A],
E [auth A],
I [auth B],
J [auth B]
ZINC ION
Zn
PTFCDOFLOPIGGS-UHFFFAOYSA-N
CA

Query on CA



Download:Ideal Coordinates CCD File
D [auth A],
F [auth A],
K [auth B],
L [auth B]
CALCIUM ION
Ca
BHPQYMZQTOCNFJ-UHFFFAOYSA-N
NA

Query on NA



Download:Ideal Coordinates CCD File
G [auth A],
M [auth B]
SODIUM ION
Na
FKNQFGJONOIPTF-UHFFFAOYSA-N

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.43 Å
  • R-Value Free:  0.175 (Depositor), 0.193 (DCC) 
  • R-Value Work:  0.151 (Depositor) 
  • R-Value Observed: 0.152 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 135.616α = 90
b = 36.13β = 131.02
c = 95.755γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
PDB_EXTRACTdata extraction
ADSCdata collection
MOSFLMdata reduction
SCALAdata scaling
AMoREphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2014-03-05
    Type: Initial release
  • Version 1.1: 2024-03-20
    Changes: Data collection, Database references, Derived calculations